qPCR for Residual DNA Analysis

Quantitative PCR (qPCR), also known as real-time PCR, is a molecular biology technique used to amplify and simultaneously quantify a targeted DNA molecule. In CMC, it is a workhorse method for the detection and quantification of residual DNA impurities.

• Legacy Techniques: Traditional endpoint PCR followed by gel electrophoresis, which was not quantitative. Southern blotting was sometimes used for detection but was slow, complex, and unsuitable for quantitative QC applications.
• Established Standard: Quantitative PCR (qPCR) based on TaqMan™ probe chemistry or SYBR™ Green dye. It provides sensitive, quantitative results in a high-throughput plate format and is the most common method for residual DNA testing in QC labs.
• Emerging Alternatives: Digital PCR (dPCR) is emerging as a higher-precision alternative, as it provides absolute quantification without a standard curve. However, qPCR remains prevalent due to its speed, cost-effectiveness, and established history.

qPCR amplifies a specific target DNA sequence through repeated thermal cycles. The scientific principle is the real-time monitoring of this amplification. A fluorescent probe or dye is included in the reaction, which generates a signal that increases in direct proportion to the amount of amplified DNA. The cycle at which this signal crosses a detection threshold (the Cq/Ct value) is inversely proportional to the initial amount of target DNA, allowing for precise quantification when compared to a standard curve.

• Output: An amplification plot (fluorescence vs. cycle number) and a standard curve (Cq vs. log concentration).
• Analysis: The software generates a standard curve from the known standards and uses its linear regression equation to calculate the DNA concentration in the unknown samples based on their Cq values.
• Interpretation: The calculated amount of residual DNA (often reported in ng/dose or pg/µg of protein) is compared to the acceptance criterion (commonly ≤10 ng per dose, unless otherwise justified by product-specific risk assessment). For the result to be valid, the standard curve must meet its criteria (e.g., R² > 0.99, specific slope and efficiency), and controls must perform as expected.

• High Sensitivity: qPCR is extremely sensitive and can detect very low levels of DNA contamination, as required by regulatory agencies.
• High Throughput: The 96- or 384-well plate format allows for the efficient analysis of many samples, standards, and controls in a single run.
• Robust & Well-Understood: The technology is mature, and methods are generally robust and reproducible in a QC environment.
• Specific: The use of specific primers and probes allows for the precise quantification of DNA from a particular source (e.g., CHO host cell DNA).

• Standard Curve Dependent: Accuracy depends heavily on the quality of the DNA standard curve as well as reaction efficiency and assay design.
• Susceptible to Inhibition: Components from the sample matrix can inhibit the PCR reaction, leading to inaccurate (underestimated) results. Sample extraction and dilution strategies are critical.
• Variability: Can exhibit higher well-to-well and day-to-day variability compared to dPCR.

• Specificity: The assay must be shown to be specific for the target DNA (e.g., host cell DNA) and not cross-react with other DNA in the sample (e.g., the product's own DNA).
• Limit of Quantification (LOQ): The LOQ must be demonstrated to be sufficiently sensitive to measure residual DNA at levels well below the regulatory acceptance limit.
• Accuracy: Accuracy is typically demonstrated through spike recovery experiments, showing that known amounts of DNA added to the sample matrix can be recovered quantitatively without inhibition
• Linearity: The standard curve must be linear over a defined concentration range, with a high correlation coefficient (R²) and a specific slope value.

• mAbs & Proteins: A mandatory release test to quantify residual host cell DNA from the production cells (e.g., CHO, E. coli).
• Gene Therapy (AAVs): A critical safety test used to quantify both residual host cell DNA and residual plasmid DNA from the transient transfection manufacturing process.
• mRNA-LNP Products: Used to quantify residual plasmid DNA template that was used to create the mRNA via in vitro transcription